NEW YORK (AP) _ Under immense regulatory and competitive pressure, Schering-Plough Corp. said Friday it planned to switch its blockbuster allergy prescription medicine Claritin to an over-the-counter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback